Form RW ARTELO BIOSCIENCES, INC.
Artelo Biosciences, Inc.
505 Lomas Santa Fe, Suite 160
Solana Beach, CA 92075
March 27, 2026
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC. 20549
Attn: Doris Stacey Gama
| Re: | Artelo Biosciences, Inc. |
|
| Request for Withdrawal |
|
| Registration Statement on Form S-1 (File No. 333-294506) |
Ladies and Gentlemen,
Pursuant to Rule 477 of the Securities Act of 1933, as amended (“Securities Act”), Artelo Biosciences, Inc. (the “Company”) hereby requests the withdrawal of its Registration Statement on Form S-1 (File No. 333-294506), initially filed with the U.S. Securities and Exchange Commission (“SEC”) on March 20, 2026, which became effective on March 25, 2026, together with all exhibits thereto (the “Registration Statement”), with such application for withdrawal to be approved effective as of the date first set forth above or at the earliest practical date thereafter.
The Company is seeking withdrawal of the Registration Statement as it does not intend to pursue the contemplated offering of the securities covered by the Registration Statement at this time. The Company confirms that no securities of the Company were issued or sold pursuant to the Registration Statement.
The Company acknowledges that no refund will be made for fees paid to the SEC in connection with the filing of the Registration Statement. However, in accordance with Rule 457(p) under the Securities Act, the Company requests that all fees paid to the SEC in connection with the filing of the Registration Statement be credited for future use.
We would be grateful if you could please send a copy of the written order granting withdrawal of the Registration Statement to Louis A. Bevilacqua of Bevilacqua PLLC via email at [email protected].
If you have any further questions regarding this request for withdrawal, or if you require any additional information, please contact Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100 or [email protected].
|
| Respectfully, |
| |
|
|
|
|
|
|
| Artelo Biosciences, Inc. |
| |
|
|
|
|
|
|
| By: | /s/ Gregory D. Gorgas |
|
|
|
| Gregory D. Gorgas |
|
|
|
| Chief Executive Officer |
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netwrix Unveils New AI Governance Capabilities for Hybrid Microsoft Environments
- District Copper Receives Government Approval and Contracts Quantec Geoscience for DCIP Survey at Flagship Copper Keg Porphyry Copper Project
- Gregorys Coffee Expands Long Island Footprint, Signing The Operators Behind NYC's Beloved Pop's Pizza
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share